Teh‐Ching Chu

405 total citations
31 papers, 339 citations indexed

About

Teh‐Ching Chu is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Ophthalmology. According to data from OpenAlex, Teh‐Ching Chu has authored 31 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 10 papers in Ophthalmology. Recurrent topics in Teh‐Ching Chu's work include Glaucoma and retinal disorders (10 papers), Nitric Oxide and Endothelin Effects (7 papers) and Receptor Mechanisms and Signaling (5 papers). Teh‐Ching Chu is often cited by papers focused on Glaucoma and retinal disorders (10 papers), Nitric Oxide and Endothelin Effects (7 papers) and Receptor Mechanisms and Signaling (5 papers). Teh‐Ching Chu collaborates with scholars based in United States and Japan. Teh‐Ching Chu's co-authors include David E. Potter, Oscar A. Candia, Qing He, Robin R. Socci, Joan C. Han, Keith Green, Warren S. Rehm, Grace Han, Charles Gluchowski and Wai C. Wong and has published in prestigious journals such as Biochimica et Biophysica Acta (BBA) - Biomembranes, Experimental Eye Research and Microchemical Journal.

In The Last Decade

Teh‐Ching Chu

31 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Teh‐Ching Chu United States 12 181 105 98 50 30 31 339
Michael A. Kapin United States 11 220 1.2× 208 2.0× 90 0.9× 24 0.5× 23 0.8× 18 450
Kenjiro Ogawa Japan 6 145 0.8× 67 0.6× 60 0.6× 27 0.5× 15 0.5× 6 319
Alden Mead United States 9 127 0.7× 195 1.9× 45 0.5× 43 0.9× 58 1.9× 12 332
Liping Zhou China 11 104 0.6× 34 0.3× 38 0.4× 51 1.0× 19 0.6× 27 353
William Cheung United Kingdom 11 261 1.4× 299 2.8× 45 0.5× 96 1.9× 22 0.7× 25 548
Firas Jammoul France 6 139 0.8× 102 1.0× 85 0.9× 98 2.0× 7 0.2× 7 370
Daniele Ferrari Italy 9 62 0.3× 95 0.9× 41 0.4× 32 0.6× 53 1.8× 23 307
Toshio Narimatsu Japan 8 194 1.1× 172 1.6× 26 0.3× 25 0.5× 13 0.4× 12 363
Talisia Quallo United Kingdom 6 123 0.7× 11 0.1× 102 1.0× 119 2.4× 64 2.1× 6 435
Saumya Nagar United States 7 172 1.0× 26 0.2× 67 0.7× 53 1.1× 9 0.3× 9 265

Countries citing papers authored by Teh‐Ching Chu

Since Specialization
Citations

This map shows the geographic impact of Teh‐Ching Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teh‐Ching Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teh‐Ching Chu more than expected).

Fields of papers citing papers by Teh‐Ching Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teh‐Ching Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teh‐Ching Chu. The network helps show where Teh‐Ching Chu may publish in the future.

Co-authorship network of co-authors of Teh‐Ching Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Teh‐Ching Chu. A scholar is included among the top collaborators of Teh‐Ching Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teh‐Ching Chu. Teh‐Ching Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Socci, Robin R., et al.. (2004). PD128,907 Induces Ocular Hypotension in Rabbits: Involvement of D 2 /D 3 Dopamine Receptors and Brain Natriuretic Peptide. Journal of Ocular Pharmacology and Therapeutics. 20(1). 15–23. 4 indexed citations
2.
Socci, Robin R., et al.. (2003). 4-Aminopyridine Transiently Increases Intraocular Pressure in Rabbits. Pharmacology. 69(2). 108–114. 3 indexed citations
3.
Zhong, Lichun, et al.. (2003). CNP-Induced Changes in pH i , cGMP/cAMP and mRNA Expression of Natriuretic Peptide Receptors in Human Trabecular Meshwork Cells. Journal of Ocular Pharmacology and Therapeutics. 19(5). 425–436. 3 indexed citations
4.
Chu, Teh‐Ching, Qing He, & David E. Potter. (2002). Biodegradable Calcium Phosphate Nanoparticles as a New Vehicle for Delivery of a Potential Ocular Hypotensive Agent. Journal of Ocular Pharmacology and Therapeutics. 18(6). 507–514. 28 indexed citations
5.
Chu, Teh‐Ching & David E. Potter. (2002). Ocular Hypotension Induced by Electroacupuncture. Journal of Ocular Pharmacology and Therapeutics. 18(4). 293–305. 25 indexed citations
7.
Chu, Teh‐Ching, et al.. (2001). Naphazoline-induced Suppression of Aqueous Humor Pressure and Flow: Involvement of Central and Peripheral α2/I1Receptors. Experimental Eye Research. 72(3). 331–339. 7 indexed citations
8.
Chu, Teh‐Ching, et al.. (1999). Intraocular Pressure Lowering by S-allylmercaptocysteine in Rabbits. Journal of Ocular Pharmacology and Therapeutics. 15(1). 9–17. 4 indexed citations
9.
Chu, Teh‐Ching, et al.. (1999). 8OH-DPAT-Induced Ocular Hypotension: Sites and Mechanisms of Action. Experimental Eye Research. 69(2). 227–238. 18 indexed citations
10.
Chu, Teh‐Ching, et al.. (1999). Potential Sites of Action of TNPA: A Dopamine-2 Receptor Agonist. Experimental Eye Research. 69(6). 611–616. 14 indexed citations
11.
Potter, David E., et al.. (1998). Lisuride Acts at Multiple Sites to Induce Ocular Hypotension and Mydriasis. Pharmacology. 57(5). 249–260. 10 indexed citations
12.
Chu, Teh‐Ching, et al.. (1997). Potential Mechanisms of Moxonidine-Induced Ocular Hypotension: Role of Norepinephrine. Journal of Ocular Pharmacology and Therapeutics. 13(6). 489–496. 14 indexed citations
13.
Chu, Teh‐Ching, Robin R. Socci, & David E. Potter. (1997). Moxonidine-lnduced Inhibition of Norepinephrine Release in Monkey and Rabbit Ciliary Bodies: Role of cGMP. Pharmacology. 55(4). 211–216. 2 indexed citations
14.
Williams, Evan F., et al.. (1996). Comparison of Nucleoside Transport Binding Sites in Rabbit Iris-Ciliary Body and Cultured Rabbit Nonpigmented Ciliary Epithelial Cells. Journal of Ocular Pharmacology and Therapeutics. 12(4). 461–469. 4 indexed citations
15.
Chu, Teh‐Ching, et al.. (1996). Rilmenidine-induced ocular hypotension: Role of imidazoline1and alpha2receptors. Current Eye Research. 15(9). 943–950. 11 indexed citations
16.
Chu, Teh‐Ching, et al.. (1996). Oxymetazoline: Potential Mechanisms of Inhibitory Effects on Aqueous Humor Dynamics. Pharmacology. 53(4). 259–270. 11 indexed citations
17.
Chu, Teh‐Ching, et al.. (1994). Alpha-2 Adrenoceptor Mediated Changes in Aqueous Dynamics: Effect of Pertussis Toxin. Experimental Eye Research. 58(6). 729–736. 20 indexed citations
18.
Chu, Teh‐Ching, et al.. (1993). Allicin-Induced Hypotension in Rabbit Eyes. Journal of Ocular Pharmacology and Therapeutics. 9(3). 201–209. 15 indexed citations
19.
Candia, Oscar A., et al.. (1991). Ascorbate-stimulated active Na+transport in rabbit ciliary epithelium. Current Eye Research. 10(3). 197–203. 9 indexed citations
20.
Chu, Teh‐Ching & Keith Green. (1990). Bicarbonate and DIDS effects on intracellular potential difference in rabbit ciliary epithelium. Current Eye Research. 9(3). 233–239. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026